2 completed, 1 terminated, 1 withdrawn. 4 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 4 | Completed 2, Terminated 1, Withdrawn 1 |
Follow nalmefene: new trials by email Literature Review of nalmefene trials Research Report on nalmefene
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Clinical Outcomes From Nalmefene Nalmefene Hydrochloride Injection, Naloxone Hydrochloride Injection - Opioid Overdose | Phase 4 | Withdrawn | Purdue Pharma LP | 2023-06-01 | 2023-07-12 | |
| Effect of Nalmefene on the Quality of Resuscitation in Patients Under General Anesthesia Nalmefene, normal Saline - Resuscitation | Phase 4 | Completed | RenJi Hospital | 542 | 2021-09-24 | 2026-02-25 |
| Treatment of Patients Suffering of Alcohol Dependence and Impaired Liver Function With Selincro® As-needed Use nalmefene - Alcohol Dependence | Phase 4 | Completed | H. Lundbeck A/S | 45 | 2014-09-01 | 2016-12-14 |
| Study of 18 mg Selincro® As-needed Use, in the Treatment of Patients With Alcohol Dependence in Primary Care Selincro® 18 mg with continuous psychosocial support: Cohort A, Initial psychosocial support: Cohort B - Alcohol Dependence | Phase 4 | Terminated | H. Lundbeck A/S | 378 | 2014-08-01 | 2017-02-28 |
Alcoholism (2) · Alcohol Drinking (1) · Opiate Overdose (1)
H. Lundbeck A/S (2) · Purdue Pharma LP (1) · RenJi Hospital (1)
Germany (2) · China (1) · France (1) · Spain (1) · United Kingdom (1)
Weifeng Yu (1)
2014 (1)